Clinical Trials

Study Title:
A Phase 3, Randomized Study of CG0070 versus Observation for the Treatment of Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR-NMIBC) Following Transurethral Resection of Bladder Tumor

For more information about the trial above please contact the study team:

Medical University of South Carolina
Principal Investigator, Robert Grubb, at grubbr@musc.edu.
Study Coordinator, Renee Tucker, at tuckerr@musc.edu.

Trial opened at the following institutions: Medical University of South Carolina